Skip to content
Business Company News, Medical Health Aged Care

HeraMED Limited (ASX:HMD) ANNOUNCES SOFT LAUNCH OF HERACARE BY TELSTRA HEALTH UNDERWAY

Jane Morgan Management 3 mins read

Highlights:

  • HeraCARE will soon be available to medical practices using Telstra Health’s MedicalDirector patient management software.

  • HeraMED initially announced its partnership with Telstra Health’s MedicalDirector platform in November 2023. HeraCARE is the first remote maternity solution to join the Telstra Health digital ecosystem.

  • A soft launch was recently announced by Telstra Health at the Royal Australian College of General Practitioners (RACGP) Practice Owners Conference in Cairns, Australia.

  • The initial step in the commercial rollout focuses on recruiting 5-10 GP clinics as 'early adopters' for integrating HeraCARE into MedicalDirector, optimizing care models and commercial models.

  • On completion of the soft launch, HeraMED targets onboarding mums through Telstra Health’s extensive GP customer base by the end of calendar year 2024.

  • HeraCARE will be available within Telstra Health’s Smart Connected Care ecosystem, integrating into Telstra Health’s core platforms.

  • This partnership supports HeraMED’s commercialisation strategy targeting the GP vertical, enhancing prenatal and postpartum maternity care experiences.

SYDNEY AUSTRALIA,– June 24, 2024 – HeraMED Limited (ASX) a leader in the digital transformation of maternity care, today announced the soft launch of HeraCARE within the Telstra Health ecosystem through targeted GP clinics.

In November 2023, HeraMED announced its partnership with Telstra Health’s MedicalDirector platform servicing GP and healthcare professionals, marking HeraCARE as the first remote maternity solution to join the Telstra Health digital ecosystem. The soft launch of HeraCARE into Telstra Health’s Smart Connected Care was recently announced at the RACGP Practice Owners Conference in Cairns, Australia.

The initial step in the commercial rollout focuses on recruiting the first group of GP clinics ('early adopters') for integrating HeraCARE into MedicalDirector and GP workflows. This phase aims to optimize care and commercial models while gathering feedback from the Beta Program before a full launch to the larger network. On completion of the soft launch, HeraMED anticipates marketing to the entire GP clinic customer base and onboarding mums through Telstra Health’s GP clinics by the end of calendar year 2024.

HeraMED and Telstra Health will jointly promote the integration of HeraCARE into the Smart Connected Care ecosystem through education and marketing initiatives as part of the Smart Partner Marketing Plan.

CEO of HeraMED, Anoushka Gungadin, stated, "HeraCARE is a mum-centric solution and the partnership with Telstra Health allows us to expand access to care for many more mums, given the significant role GPs play in maternity, pregnancy and postpartum care. Following integration and commercial rollout within this new ecosystem, we are targeting the onboarding of mums through GP practices by the end of calendar year 2024. This aligns with the four-point plan both for commercialisation and strategic partnership while redefining how maternity care is delivered and experienced."

About Telstra Health: At Telstra Health, we work to improve lives through digitally-enabled care for our community.

Our vision drives us as we strive to realise a connected and improved digital health experience for all. We have established a unique footprint, both locally in Australia and internationally, and we have deep experience and expertise across the entire spectrum of health, aged care and social services.

We work with care providers in the hospital, health service, general practice, pharmacy, and aged care sectors to connect health information, clinicians and consumers. We also partner with industry-leading specialist organisations to successfully deliver critical national services.

Our clinical and administrative systems, population health solutions, and information exchange platforms help providers and government organisations to improve the quality, safety and efficiency of the healthcare they deliver. We also help enable clinicians to deliver care in new ways through our virtual care and consumer solutions. We support healthcare organisations to make better informed decisions through our advisory services and end-to-end analytics and artificial intelligence solutions.

Collectively, our digital health solutions help to solve some of the biggest challenges facing the health and aged care sectors and represent an important element in delivering outcomes that matter to patients and clinicians.

 


About us:

About HeraMED Limited (ASX): HeraMED is an innovative medical data and technology company leading the digital transformation of maternity care by revolutionising the prenatal and postpartum experience with its hybrid maternity care platform. HeraMED offers a proprietary platform that utilises hardware and software to reshape the Doctor/Patient relationship using its clinically validated in-home foetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, and big data.

The Company’s proprietary offering, HeraCARE, has been engineered to offer a fully integrated maternal health ecosystem designed to deliver better care at a lower cost, ensure expectant mothers are engaged, informed and well-supported, allow healthcare professionals to provide the highest quality care and enable early detection and prevention of potential risks.

 


Contact details:

Investor & Media Relations
Jane Morgan
M: +61 405 555 618
E: jm@janemorganmanagement.com.au

Media

More from this category

  • Community, Medical Health Aged Care
  • 22/07/2024
  • 17:24
Odyssey Lifestyle Care Communities

Dancing and dining; seniors celebrate four fabulous years

Odyssey Lifestyle Care Communities recently celebrated a significant milestone in style, marking its fourth birthday with an evening full of fun, fantastic food and…

  • Contains:
  • Biotechnology, Medical Health Aged Care
  • 22/07/2024
  • 12:56
Illumina

Research into psychedelic medicines to treat anxiety wins ANS Illumina Neurogenomics Award 2024

Genomic technologies to discover biological markers, within the blood, that could predict patient response to psychedelic medicines such as psilocybin. MELBOURNE, AUSTRALIA, 22 July 2024 - Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the winner of the annual Australasian Neuroscience Society (ANS) Illumina Neurogenomics Research Award as Dr Andrew Gibbons from the Department of Psychiatry, School of Clinical Sciences at Monash Health. “Psilocybin, a chemical produced by hallucinogenic mushrooms, is a psychedelic medicine that has shown to meaningfully reduce symptoms of generalized anxiety during psychotherapy for patients. However, not all patients respond.…

  • Contains:
  • Industrial Relations, Medical Health Aged Care
  • 22/07/2024
  • 11:12
Australian Nursing and Midwifery Federation (Victorian Branch)

Bolton Clarke nurses and carers to hold stop-work rally – Mon 22 July, 1pm-2pm

WHATANMF Bolton Clarke members two-hour stop work and community rally for fair pay and conditionsACTU Secretary Sally McManus and VTHC Secretary Luke Hilakari will address the rally WHENMonday, 22 July 2024, 1pm-3pm. (Speakers will start 1.05pm sharp) WHEREoutside Bolton Clarke’s Victorian headquarters, 347 Burwood Highway, Forest Hill Bolton Clarke nurses, personal care workers and midwives will stop work for two hours on Monday 22 July to rally for better pay and conditions. For the past 18 months, the Australian Nursing and Midwifery Federation (Victorian Branch) has been negotiating wages and conditions on behalf of about 1700 members working across Bolton…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.